{"id":541436,"date":"2025-07-22T06:00:32","date_gmt":"2025-07-22T06:00:32","guid":{"rendered":"https:\/\/www.capgemini.com\/co-es\/?p=541436&#038;preview=true&#038;preview_id=541436"},"modified":"2025-07-22T06:00:44","modified_gmt":"2025-07-22T06:00:44","slug":"key-takeaways-from-biotechx-2024-a-shift-towards-realism-and-practical-applications","status":"publish","type":"post","link":"https:\/\/www.capgemini.com\/co-es\/insights\/expert-perspectives\/key-takeaways-from-biotechx-2024-a-shift-towards-realism-and-practical-applications\/","title":{"rendered":"Key takeaways from BioTechX 2024: A shift towards realism and practical applications"},"content":{"rendered":"\n<header class=\"wp-block-cg-blocks-hero-blogs header-hero-blogs\"><div class=\"container\"><div class=\"hero-blogs\"><div class=\"hero-blogs-content-wrapper\"><div class=\"row\"><div class=\"col-12\"><div class=\"header-title\"><h1>Key takeaways from BioTechX 2024: A shift towards realism and practical applications<\/h1><\/div><\/div><\/div><\/div><div class=\"hero-blogs-bottom\"><div class=\"header-author\"><div class=\"author-img\"><img decoding=\"async\" src=\"https:\/\/www.capgemini.com\/co-es\/wp-content\/uploads\/sites\/25\/2021\/08\/cg-logo-3.png?w=200&amp;quality=10\" alt=\"\" loading=\"lazy\"\/><\/div><div class=\"author-name-date\"><h5 class=\"author-name\">ÎÚÑ»´«Ã½<\/h5><h5 class=\"blog-date\">Nov 6, 2024<\/h5><\/div><\/div><div class=\"brand-image\"> <\/div><\/div><\/div><\/div><\/header>\n\n\n\n<section class=\"wp-block-cg-blocks-intro-para undefined section section--intro\"><div class=\"intro-para\"><div class=\"container\"><div class=\"row\"><div class=\"col-12 col-md-1\"><nav class=\"article-social\"><ul class=\"social-nav\"><li class=\"ip-order-fb\"><a href=\"https:\/\/www.facebook.com\/sharer\/sharer.php?u=https:\/\/www.capgemini.com\/insights\/expert-perspectives\/key-takeaways-from-biotechx-2024-a-shift-towards-realism-and-practical-applications\/\" target=\"_blank\" rel=\"noopener noreferrer\" title=\"opens in a new window\"><i aria-hidden=\"true\" class=\"icon-fb\"><\/i><span class=\"sr-only\">Facebook<\/span><\/a><\/li><li class=\"ip-order-li\"><a href=\"https:\/\/www.linkedin.com\/shareArticle?url=https:\/\/www.capgemini.com\/insights\/expert-perspectives\/key-takeaways-from-biotechx-2024-a-shift-towards-realism-and-practical-applications\/\" target=\"_blank\" rel=\"noopener noreferrer\" title=\"opens in a new window\"><i aria-hidden=\"true\" class=\"icon-li\"><\/i><span class=\"sr-only\">Linkedin<\/span><\/a><\/li><\/ul><\/nav><\/div><div class=\"col-12 col-md-11 col-lg-10\"><h2 class=\"intro-para-title\">The <a href=\"https:\/\/www.terrapinn.com\/conference\/biotechx\/index.stm\">BioTechX event<\/a> in Basel in October was a major gathering for biotech and pharma professionals. This year, there was a different vibe compared to last year.<br><\/h2><\/div><\/div><\/div><\/div><\/section>\n\n\n\n<section class=\"wp-block-cg-blocks-group undefined section section--article-content\"><div class=\"article-main-content\"><div class=\"container\"><div class=\"row\"><div class=\"col-12 col-md-11 col-lg-10 offset-md-1 offset-lg-1\"><div class=\"article-text article-quote-text\">\n<h4 class=\"wp-block-heading\" id=\"h-this-year-s-event-marked-a-noticeable-shift-from-the-excitement-of-previous-years-to-a-more-grounded-and-realistic-approach-to-the-advancements-in-ai-and-biotechnology-we-had-a-great-time-at-the-event-and-are-excited-to-share-our-key-takeaways-with-you\">This year&#8217;s event marked a noticeable shift from the excitement of previous years to a more grounded and realistic approach to the advancements in AI and biotechnology. We had a great time at the event and are excited to share our key takeaways with you.<\/h4>\n\n\n\n<p><\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-1-the-realization-of-ai-s-potential\"><strong>1. The Realization of AI&#8217;s Potential<\/strong><\/h4>\n\n\n\n<p>One of the standout themes at BioTechX 2024 was the real progress in AI, especially Generative AI. Last year, we were all about the potential of large language models and generative AI. This year, it was all about real-world applications and measurable impacts. For example, a keynote presentation showcased a generative AI platform that\u2019s been scaled up, boosting efficiency by 10-20% for its 15,000 users. This shift from theoretical potential to practical implementation was a recurring theme throughout the event.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-2-the-importance-of-trustworthy-data\"><strong>2. The Importance of Trustworthy Data<\/strong><\/h4>\n\n\n\n<p>As organizations continue to explore AI applications, the emphasis on trustworthy data has never been greater. Several sessions highlighted that the success of AI models in life sciences heavily depends on reliable data. While defining and obtaining trustworthy data is challenging, there were successful examples where robust data foundations led to significant advancements. The consensus was clear: without trustworthy data, AI models can&#8217;t reach their full potential.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-3-the-role-of-multi-agent-systems\"><strong>3. The Role of Multi-Agent Systems<\/strong><\/h4>\n\n\n\n<p>Another hot topic was multi-agent systems. It\u2019s clear that the future of AI in life sciences involves multiple specialized AI models working together. This approach, known as agentic AI, uses a suite of models, each with its own specialization, to tackle complex scientific workflows. This method not only enhances AI efficiency but also addresses the unique challenges of life sciences research.<\/p>\n\n\n\n<figure class=\"wp-block-image aligncenter size-full is-resized\"><img decoding=\"async\" src=\"https:\/\/www.capgemini.com\/wp-content\/uploads\/2024\/11\/Biotech-blog-_Pic.svg\" alt=\"\" class=\"wp-image-1071520\" style=\"aspect-ratio:16\/9;object-fit:cover;width:700px\"\/><\/figure>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-4-the-need-for-pragmatic-approaches-to-fair-data\"><strong>4. The Need for Pragmatic Approaches to FAIR Data<\/strong><\/h4>\n\n\n\n<p>Discussions also touched on the need for pragmatic approaches to FAIR (Findable, Accessible, Interoperable, and Reusable) data. While everyone agrees on the importance of FAIR data, achieving perfect FAIRness isn&#8217;t always practical. The key takeaway was that data should be FAIR enough to be functional and useful, without overcomplicating the process.  <\/p>\n\n\n\n<p><em><strong>Stay tuned for our next blog, where we&#8217;ll dive deeper into our panel discussion on FAIR data. <\/strong><\/em><\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-5-the-future-of-quantum-computing-in-drug-discovery\"><strong>5. The Future of Quantum Computing in Drug Discovery<\/strong><\/h4>\n\n\n\n<p>Quantum computing was another exciting topic at the event. While it is still seen as a technology with a 5 to 10-year horizon, its potential to revolutionize drug discovery was widely discussed. Quantum computing is expected to solve problems that current technologies cannot, offering new ways to understand and manipulate biological systems. However, it was also acknowledged that quantum will be more complementing rather than replacing existing technologies. One takeaway is that we have to think about how to combine classical technologies and high-performance computing (HPC) cleverly with quantum technologies and think out of the box to achieve revolutionary advancements.<\/p>\n\n\n\n<p>In addition to its potential, the event highlighted various use cases and benchmarks of existing quantum algorithms and hardware. These discussions underscored the significant hardware development needed to address interesting use cases in the pharmaceutical industry. Nevertheless, it is crucial to start now. Beyond hardware advancements, there is a substantial amount of work required on the implementation side, such as developing effective error correction strategies. On the software side, optimizing quantum algorithms is essential to achieve these goals as soon as possible.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-6-addressing-the-productivity-crisis-in-r-amp-d\"><strong>6. Addressing the Productivity Crisis in R&amp;D<\/strong><\/h4>\n\n\n\n<p>No it&#8217;s not new, but a recurring topic at BioTechX 2024 was the ongoing productivity crisis in R&amp;D. Despite increased spending, the number of new drug approvals has not kept pace (<a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S135964462400285X#b0065\">Research and development costs, currently exceeding $3.5 billion per novel drug, reflect a five-decade decline in pharmaceutical R&amp;D efficiency<\/a>.). The event highlighted the need for innovative solutions to boost productivity while reducing costs. AI and other advanced technologies were seen as crucial to achieving these goals, with a focus on practical applications that can deliver measurable results.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-conclusion\"><strong>Conclusion<\/strong><\/h3>\n\n\n\n<p>In conclusion, BioTechX 2024 was a pivotal event that highlighted the shift towards realism and practical applications in the biotech and life sciences industries. The discussions underscored the importance of trustworthy data, the potential of multi-agent systems, and the future role of quantum computing. As the industry continues to evolve, these insights will be crucial in guiding future advancements and addressing the challenges ahead.<\/p>\n\n\n\n<div class=\"wp-block-buttons is-layout-flex wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/www.capgemini.com\/industries\/life-sciences\/\"><strong>Learn More about Life Sciences<\/strong><\/a><\/div>\n<\/div>\n<\/div><\/div><\/div><\/div><\/div><\/section>\n\n\n\n<section class=\"wp-block-cg-blocks-wrapper-people-slider section section--expert-slider wrapper-people-slider undefined\"><div class=\"container\"><div class=\"content-title\"><h2 data-maxlength=\"34\" class=\"people-heading-title\">Authors<\/h2><\/div><\/div><div class=\"slider slider-boxed\"><div class=\"container\"><div class=\"slider-window\"><div class=\"slider-list\">\t\t<div class=\"slide\">\n\t\t\t<div class=\"box\">\n\t\t\t\t<div class=\"row\">\n\t\t\t\t\t<div class=\"col-md-6 col-lg-4 box-img-wrapper\">\n\t\t\t\t\t\t<img decoding=\"async\" loading=\"lazy\" src=\"https:\/\/www.capgemini.com\/co-es\/wp-content\/uploads\/sites\/25\/2025\/07\/Justin-Melnick.jpg\" alt=\"Justin Melnick\"\/>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t<div class=\"col-md-6 col-lg-8 box-inner\">\n\t\t\t\t\t\t<div class=\"row title-social-media-header\">\n\t\t\t\t\t\t\t<div class=\"col-md-12 col-lg-6 mbl-social-icon\">\n\t\t\t\t\t\t\t\t<ul class=\"social-nav\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li><a aria-label=\"Linkedin\" target=\"_blank\" href=\"https:\/\/www.linkedin.com\/in\/justinrmelnick\/\"><i aria-hidden=\"true\" class=\"icon-li\"><\/i><\/a><\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/ul>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<div class=\"col-md-12 col-lg-6 box-container\">\n\t\t\t\t\t\t\t\t<div class=\"box-title\">\n\t\t\t\t\t\t\t\t\t<h3 class=\"people-profile-title\">Justin Melnick<\/h3>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span>R&amp;D Transformation Partner Life Sciences<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<div class=\"col-md-12 col-lg-6 social-box-container dkt-social-icon\">\n\t\t\t\t\t\t\t\t<ul class=\"social-nav\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li><a aria-label=\"Linkedin\" target=\"_blank\" href=\"https:\/\/www.linkedin.com\/in\/justinrmelnick\/\"><i aria-hidden=\"true\" class=\"icon-li\"><\/i><\/a><\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/ul>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"people-info\">Justin leads ÎÚÑ»´«Ã½&#8217;s R&#038;D for life sciences offer and is focused on the translatory role between the worlds of computational and biological sciences. He has 12 years experience in figuring out how to utilize technology to fundamentally impact human lives. A firm believer in tech-for-good and energized by the opportunity and ability to utilize technology in new ways that rewrite the business models of the life sciences world.<\/div>\n\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\n\n\t\t<div class=\"slide\">\n\t\t\t<div class=\"box\">\n\t\t\t\t<div class=\"row\">\n\t\t\t\t\t<div class=\"col-md-6 col-lg-4 box-img-wrapper\">\n\t\t\t\t\t\t<img decoding=\"async\" loading=\"lazy\" src=\"https:\/\/www.capgemini.com\/co-es\/wp-content\/uploads\/sites\/25\/2025\/07\/Franziska-Wolff.jpg\" alt=\"Franziska Wolff\"\/>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t<div class=\"col-md-6 col-lg-8 box-inner\">\n\t\t\t\t\t\t<div class=\"row title-social-media-header\">\n\t\t\t\t\t\t\t<div class=\"col-md-12 col-lg-6 mbl-social-icon\">\n\t\t\t\t\t\t\t\t<ul class=\"social-nav\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t\t\t<a class=\"subnav-button--form\" href=\"javascript:void(0)\" aria-label=\"contact us\" data-bs-toggle=\"modal\" data-bs-target=\"#WPBa15fcd15_e197_41d9_9792_b5f54baf4210\" data-bs-expert-title=\"1\">\n\t\t\t\t\t\t\t\t\t\t\t\t<i aria-hidden=\"true\" class=\"ico-form\"><\/i>\n\t\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li><a aria-label=\"Linkedin\" target=\"_blank\" href=\"https:\/\/www.linkedin.com\/in\/franziska-wolff-45aa9a10a\/\"><i aria-hidden=\"true\" class=\"icon-li\"><\/i><\/a><\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/ul>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<div class=\"col-md-12 col-lg-6 box-container\">\n\t\t\t\t\t\t\t\t<div class=\"box-title\">\n\t\t\t\t\t\t\t\t\t<h3 class=\"people-profile-title\">Franziska Wolff<\/h3>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span>Professional II, Altran Deutschland S.A.S. Co. KG<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<div class=\"col-md-12 col-lg-6 social-box-container dkt-social-icon\">\n\t\t\t\t\t\t\t\t<ul class=\"social-nav\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t\t\t<a class=\"subnav-button--form\" href=\"javascript:void(0)\" aria-label=\"contact us\" data-bs-toggle=\"modal\" data-bs-target=\"#WPBa15fcd15_e197_41d9_9792_b5f54baf4210\" data-bs-expert-title=\"Franziska Wolff\">\n\t\t\t\t\t\t\t\t\t\t\t\t<i aria-hidden=\"true\" class=\"ico-form\"><\/i>\n\t\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li><a aria-label=\"Linkedin\" target=\"_blank\" href=\"https:\/\/www.linkedin.com\/in\/franziska-wolff-45aa9a10a\/\"><i aria-hidden=\"true\" class=\"icon-li\"><\/i><\/a><\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/ul>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"people-info\">With my strong academic background in Quantum Chemistry and Life Sciences, I am proud to bring quantum technology to the next level by finding use cases and actively exploring new possibilities for quantum computing in the industry. With my knowledge from my PhD in Theoretical Chemistry about quantum chemical simulations of light-triggered processes in complex environments, combined with my experience in the successful implementation of projects in the field of data science and data quality, I am excited to embark on the future of quantum computers and implement successful projects.<\/div>\n\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\t\t\t\t\t<div class=\"modal\" id=\"WPBa15fcd15_e197_41d9_9792_b5f54baf4210\">\n\t\t\t\t\t<div class=\"modal-dialog modal-dialog-centered modal-lg modal-dialog-scrollable landing-page-modals\">\n\t\t\t\t\t\t<div class=\"modal-content\">\n\t\t\t\t\t\t\t<div class=\"modal-header\">\n\t\t\t\t\t\t\t\t<button type=\"button\" class=\"btn-close\" aria-label=\"close\" data-bs-dismiss=\"modal\"><\/button>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<div class=\"modal-body\">\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<div class=\"mf_forms__container \">\n\t\t\t\t\t\t\t\t<form id=\"mf_form_344241_842081787\" class=\"mf_form__form row needs-validation\" action=\"\" method=\"post\" enctype=\"multipart\/form-data\" data-nosnippet>\n\n\t\t\t\t\t\t\t\t<input type=\"hidden\" name=\"form_id\" data-validate=\"number\" class=\"mf_form__id\" value=\"344241\" \/>\n\t\t\t\t<input type=\"hidden\" name=\"form_title\" class=\"mf_form__title\" value=\"\" \/>\n\t\t\t\t<input type=\"hidden\" name=\"wp_rest_nonce\" class=\"mf_form__wp_rest_nonce\" value=\"fe9e414504\" \/>\n\n\t\t\t\t<input type=\"hidden\" name=\"mf_form_conditional_logic\" class=\"mf_form__title conditional_logic\" value=\"\" \/>\n\t\t\t\t\n\t\t\t\t<input type=\"hidden\" name=\"mf_form_fields_country_dpo_field\" class=\"mf_form__title conditional_logic mf_form_fields_country_dpo_field\" value=\"\" \/>\n\n\t\t\t\t<input type = \"hidden\" name = \"mf_form_field_validate\" class = \"mf_form_field_validate\" \/>\n\t\t\t<\/form>\n\n\t\t\t<div class=\"mf_form__success\" tabindex=\"0\" role=\"alert\">\n\t\t\t\t\t\t\t\t<p>Gracias! Hemos recibido tu formulario.\t\t\t\t<\/p>\n\t\t\t<\/div>\n\t\t\t<div class=\"mf_form__errors\">\n\t\t\t\t<p>Lo sentimos, el env\u00edo del formulario fall\u00f3. Int\u00e9ntalo de nuevo.<\/p>\n\t\t\t<\/div>\n\t\t\t\t<\/div>\n\n\t\t<script>\n\t\t\twindow.MF_CONFIG344241 = {\"344241\":{\"errors\":[],\"redirect\":\"\"}};\n\t\t<\/script>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div><\/div><\/div><div class=\"slider-nav\"><button class=\"slider-prev inactive\" aria-label=\"Slider-previous\" tabindex=\"-1\"><\/button><ul class=\"slider-paginator\"><\/ul><button class=\"slider-next\" aria-label=\"Slider-next\"><\/button><\/div><\/div><\/section>\n","protected":false},"excerpt":{"rendered":"<p>Key takeaways from BioTechX 2024: A shift towards realism and practical applications<\/p>\n","protected":false},"author":699,"featured_media":541437,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"cg_dt_proposed_to":[],"cg_seo_hreflang_relations":"[]","cg_seo_canonical_relation":"","cg_seo_hreflang_x_default_relation":"{\"uuid\":\"52866d8a-d3a2-4265-8f98-f62de6e0fa80\",\"blogId\":\"1\",\"domain\":\"www.capgemini.com\",\"sitePath\":\"\/\",\"postLink\":\"https:\/\/www.capgemini.com\/insights\/expert-perspectives\/key-takeaways-from-biotechx-2024-a-shift-towards-realism-and-practical-applications\/\",\"postId\":1071511,\"isSaved\":true,\"isCrossLink\":false,\"hasCrossLink\":false,\"isEnabled\":true}","cg_dt_approved_content":true,"cg_dt_mandatory_content":false,"cg_dt_notes":"","cg_dg_source_changed":false,"cg_dt_link_disabled":false,"_yoast_wpseo_primary_brand":"82","_jetpack_memberships_contains_paid_content":false,"footnotes":"","featured_focal_points":""},"categories":[1],"tags":[],"brand":[82],"service":[162],"industry":[119],"partners":[],"blog-topic":[49],"content-group":[],"class_list":["post-541436","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized","brand-capgemini","service-data-ai","industry-life-sciences","blog-topic-data-and-ai"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v22.8 (Yoast SEO v22.8) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Key takeaways from BioTechX 2024: A shift towards realism and practical applications - ÎÚÑ»´«Ã½ Colombia<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.capgemini.com\/co-es\/insights\/expert-perspectives\/key-takeaways-from-biotechx-2024-a-shift-towards-realism-and-practical-applications\/\" \/>\n<meta property=\"og:locale\" content=\"es_MX\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Key takeaways from BioTechX 2024: A shift towards realism and practical applications\" \/>\n<meta property=\"og:description\" content=\"Key takeaways from BioTechX 2024: A shift towards realism and practical applications\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.capgemini.com\/co-es\/insights\/expert-perspectives\/key-takeaways-from-biotechx-2024-a-shift-towards-realism-and-practical-applications\/\" \/>\n<meta property=\"og:site_name\" content=\"ÎÚÑ»´«Ã½ Colombia\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-22T06:00:32+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-22T06:00:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.capgemini.com\/co-es\/wp-content\/uploads\/sites\/25\/2025\/10\/New-Web-preview-global.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"627\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"ÎÚÑ»´«Ã½\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"elishavalekar\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.capgemini.com\/co-es\/insights\/expert-perspectives\/key-takeaways-from-biotechx-2024-a-shift-towards-realism-and-practical-applications\/\",\"url\":\"https:\/\/www.capgemini.com\/co-es\/insights\/expert-perspectives\/key-takeaways-from-biotechx-2024-a-shift-towards-realism-and-practical-applications\/\",\"name\":\"Key takeaways from BioTechX 2024: A shift towards realism and practical applications - ÎÚÑ»´«Ã½ Colombia\",\"isPartOf\":{\"@id\":\"https:\/\/www.capgemini.com\/co-es\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.capgemini.com\/co-es\/insights\/expert-perspectives\/key-takeaways-from-biotechx-2024-a-shift-towards-realism-and-practical-applications\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.capgemini.com\/co-es\/insights\/expert-perspectives\/key-takeaways-from-biotechx-2024-a-shift-towards-realism-and-practical-applications\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.capgemini.com\/co-es\/wp-content\/uploads\/sites\/25\/2025\/07\/GettyImages-1090243542.jpg\",\"datePublished\":\"2025-07-22T06:00:32+00:00\",\"dateModified\":\"2025-07-22T06:00:44+00:00\",\"author\":{\"@id\":\"https:\/\/www.capgemini.com\/co-es\/#\/schema\/person\/d5a00e336d198ead20a92fc1ca50cc2b\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.capgemini.com\/co-es\/insights\/expert-perspectives\/key-takeaways-from-biotechx-2024-a-shift-towards-realism-and-practical-applications\/#breadcrumb\"},\"inLanguage\":\"es-MX\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.capgemini.com\/co-es\/insights\/expert-perspectives\/key-takeaways-from-biotechx-2024-a-shift-towards-realism-and-practical-applications\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es-MX\",\"@id\":\"https:\/\/www.capgemini.com\/co-es\/insights\/expert-perspectives\/key-takeaways-from-biotechx-2024-a-shift-towards-realism-and-practical-applications\/#primaryimage\",\"url\":\"https:\/\/www.capgemini.com\/co-es\/wp-content\/uploads\/sites\/25\/2025\/07\/GettyImages-1090243542.jpg\",\"contentUrl\":\"https:\/\/www.capgemini.com\/co-es\/wp-content\/uploads\/sites\/25\/2025\/07\/GettyImages-1090243542.jpg\",\"width\":2121,\"height\":1414,\"caption\":\"Scientists Working on Computer In Modern Laboratory NOTE TO INSPECTOR: all graps, dna models, charts are made by me\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.capgemini.com\/co-es\/insights\/expert-perspectives\/key-takeaways-from-biotechx-2024-a-shift-towards-realism-and-practical-applications\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.capgemini.com\/co-es\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Key takeaways from BioTechX 2024: A shift towards realism and practical applications\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.capgemini.com\/co-es\/#website\",\"url\":\"https:\/\/www.capgemini.com\/co-es\/\",\"name\":\"ÎÚÑ»´«Ã½ Colombia\",\"description\":\"ÎÚÑ»´«Ã½\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.capgemini.com\/co-es\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es-MX\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.capgemini.com\/co-es\/#\/schema\/person\/d5a00e336d198ead20a92fc1ca50cc2b\",\"name\":\"elishavalekar\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es-MX\",\"@id\":\"https:\/\/www.capgemini.com\/co-es\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/ddbecdbccdad1dd8b32a065814a45d631db326b06e3c1682c69cf1356da99377?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/ddbecdbccdad1dd8b32a065814a45d631db326b06e3c1682c69cf1356da99377?s=96&d=mm&r=g\",\"caption\":\"elishavalekar\"},\"url\":\"https:\/\/www.capgemini.com\/co-es\/author\/elishavalekar\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Key takeaways from BioTechX 2024: A shift towards realism and practical applications - ÎÚÑ»´«Ã½ Colombia","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.capgemini.com\/co-es\/insights\/expert-perspectives\/key-takeaways-from-biotechx-2024-a-shift-towards-realism-and-practical-applications\/","og_locale":"es_MX","og_type":"article","og_title":"Key takeaways from BioTechX 2024: A shift towards realism and practical applications","og_description":"Key takeaways from BioTechX 2024: A shift towards realism and practical applications","og_url":"https:\/\/www.capgemini.com\/co-es\/insights\/expert-perspectives\/key-takeaways-from-biotechx-2024-a-shift-towards-realism-and-practical-applications\/","og_site_name":"ÎÚÑ»´«Ã½ Colombia","article_published_time":"2025-07-22T06:00:32+00:00","article_modified_time":"2025-07-22T06:00:44+00:00","og_image":[{"width":1200,"height":627,"url":"https:\/\/www.capgemini.com\/co-es\/wp-content\/uploads\/sites\/25\/2025\/10\/New-Web-preview-global.jpg","type":"image\/jpeg"}],"author":"ÎÚÑ»´«Ã½","twitter_card":"summary_large_image","twitter_misc":{"Written by":"elishavalekar","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.capgemini.com\/co-es\/insights\/expert-perspectives\/key-takeaways-from-biotechx-2024-a-shift-towards-realism-and-practical-applications\/","url":"https:\/\/www.capgemini.com\/co-es\/insights\/expert-perspectives\/key-takeaways-from-biotechx-2024-a-shift-towards-realism-and-practical-applications\/","name":"Key takeaways from BioTechX 2024: A shift towards realism and practical applications - ÎÚÑ»´«Ã½ Colombia","isPartOf":{"@id":"https:\/\/www.capgemini.com\/co-es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.capgemini.com\/co-es\/insights\/expert-perspectives\/key-takeaways-from-biotechx-2024-a-shift-towards-realism-and-practical-applications\/#primaryimage"},"image":{"@id":"https:\/\/www.capgemini.com\/co-es\/insights\/expert-perspectives\/key-takeaways-from-biotechx-2024-a-shift-towards-realism-and-practical-applications\/#primaryimage"},"thumbnailUrl":"https:\/\/www.capgemini.com\/co-es\/wp-content\/uploads\/sites\/25\/2025\/07\/GettyImages-1090243542.jpg","datePublished":"2025-07-22T06:00:32+00:00","dateModified":"2025-07-22T06:00:44+00:00","author":{"@id":"https:\/\/www.capgemini.com\/co-es\/#\/schema\/person\/d5a00e336d198ead20a92fc1ca50cc2b"},"breadcrumb":{"@id":"https:\/\/www.capgemini.com\/co-es\/insights\/expert-perspectives\/key-takeaways-from-biotechx-2024-a-shift-towards-realism-and-practical-applications\/#breadcrumb"},"inLanguage":"es-MX","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.capgemini.com\/co-es\/insights\/expert-perspectives\/key-takeaways-from-biotechx-2024-a-shift-towards-realism-and-practical-applications\/"]}]},{"@type":"ImageObject","inLanguage":"es-MX","@id":"https:\/\/www.capgemini.com\/co-es\/insights\/expert-perspectives\/key-takeaways-from-biotechx-2024-a-shift-towards-realism-and-practical-applications\/#primaryimage","url":"https:\/\/www.capgemini.com\/co-es\/wp-content\/uploads\/sites\/25\/2025\/07\/GettyImages-1090243542.jpg","contentUrl":"https:\/\/www.capgemini.com\/co-es\/wp-content\/uploads\/sites\/25\/2025\/07\/GettyImages-1090243542.jpg","width":2121,"height":1414,"caption":"Scientists Working on Computer In Modern Laboratory NOTE TO INSPECTOR: all graps, dna models, charts are made by me"},{"@type":"BreadcrumbList","@id":"https:\/\/www.capgemini.com\/co-es\/insights\/expert-perspectives\/key-takeaways-from-biotechx-2024-a-shift-towards-realism-and-practical-applications\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.capgemini.com\/co-es\/"},{"@type":"ListItem","position":2,"name":"Key takeaways from BioTechX 2024: A shift towards realism and practical applications"}]},{"@type":"WebSite","@id":"https:\/\/www.capgemini.com\/co-es\/#website","url":"https:\/\/www.capgemini.com\/co-es\/","name":"ÎÚÑ»´«Ã½ Colombia","description":"ÎÚÑ»´«Ã½","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.capgemini.com\/co-es\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es-MX"},{"@type":"Person","@id":"https:\/\/www.capgemini.com\/co-es\/#\/schema\/person\/d5a00e336d198ead20a92fc1ca50cc2b","name":"elishavalekar","image":{"@type":"ImageObject","inLanguage":"es-MX","@id":"https:\/\/www.capgemini.com\/co-es\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/ddbecdbccdad1dd8b32a065814a45d631db326b06e3c1682c69cf1356da99377?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ddbecdbccdad1dd8b32a065814a45d631db326b06e3c1682c69cf1356da99377?s=96&d=mm&r=g","caption":"elishavalekar"},"url":"https:\/\/www.capgemini.com\/co-es\/author\/elishavalekar\/"}]}},"blog_topic_info":[{"id":49,"name":"Data and AI"}],"taxonomy_info":{"category":[{"id":1,"name":"Uncategorized","slug":"uncategorized"}],"brand":[{"id":82,"name":"ÎÚÑ»´«Ã½","slug":"capgemini"}],"service":[{"id":162,"name":"Data &amp; AI","slug":"data-ai"}],"industry":[{"id":119,"name":"Life sciences","slug":"life-sciences"}],"blog-topic":[{"id":49,"name":"Data and AI","slug":"data-and-ai"}],"following_users":[{"id":460,"name":"elishavalekar","slug":"elishavalekar"},{"id":224,"name":"vikramjanugade","slug":"vikramjanugade"}]},"parsely":{"version":"1.1.0","canonical_url":"https:\/\/capgemini.com\/co-es\/insights\/expert-perspectives\/key-takeaways-from-biotechx-2024-a-shift-towards-realism-and-practical-applications\/","smart_links":{"inbound":0,"outbound":0},"traffic_boost_suggestions_count":0,"meta":{"@context":"https:\/\/schema.org","@type":"NewsArticle","headline":"Key takeaways from BioTechX 2024: A shift towards realism and practical applications","url":"https:\/\/www.capgemini.com\/co-es\/insights\/expert-perspectives\/key-takeaways-from-biotechx-2024-a-shift-towards-realism-and-practical-applications\/","mainEntityOfPage":{"@type":"WebPage","@id":"https:\/\/www.capgemini.com\/co-es\/insights\/expert-perspectives\/key-takeaways-from-biotechx-2024-a-shift-towards-realism-and-practical-applications\/"},"thumbnailUrl":"https:\/\/www.capgemini.com\/co-es\/wp-content\/uploads\/sites\/25\/2025\/07\/GettyImages-1090243542.jpg?w=150&h=150&crop=1","image":{"@type":"ImageObject","url":"https:\/\/www.capgemini.com\/co-es\/wp-content\/uploads\/sites\/25\/2025\/07\/GettyImages-1090243542.jpg"},"articleSection":"Uncategorized","author":[{"@type":"Person","name":"elishavalekar"}],"creator":["elishavalekar"],"publisher":{"@type":"Organization","name":"ÎÚÑ»´«Ã½ Colombia","logo":""},"keywords":[],"dateCreated":"2025-07-22T06:00:32Z","datePublished":"2025-07-22T06:00:32Z","dateModified":"2025-07-22T06:00:44Z"},"rendered":"<meta name=\"parsely-title\" content=\"Key takeaways from BioTechX 2024: A shift towards realism and practical applications\" \/>\n<meta name=\"parsely-link\" content=\"https:\/\/www.capgemini.com\/co-es\/insights\/expert-perspectives\/key-takeaways-from-biotechx-2024-a-shift-towards-realism-and-practical-applications\/\" \/>\n<meta name=\"parsely-type\" content=\"post\" \/>\n<meta name=\"parsely-image-url\" content=\"https:\/\/www.capgemini.com\/co-es\/wp-content\/uploads\/sites\/25\/2025\/07\/GettyImages-1090243542.jpg?w=150&amp;h=150&amp;crop=1\" \/>\n<meta name=\"parsely-pub-date\" content=\"2025-07-22T06:00:32Z\" \/>\n<meta name=\"parsely-section\" content=\"Uncategorized\" \/>\n<meta name=\"parsely-author\" content=\"elishavalekar\" \/>","tracker_url":"https:\/\/cdn.parsely.com\/keys\/capgemini.com\/p.js"},"jetpack_featured_media_url":"https:\/\/www.capgemini.com\/co-es\/wp-content\/uploads\/sites\/25\/2025\/07\/GettyImages-1090243542.jpg","featured_image_src":"https:\/\/www.capgemini.com\/co-es\/wp-content\/uploads\/sites\/25\/2025\/07\/GettyImages-1090243542.jpg","featured_image_alt":"","jetpack_sharing_enabled":true,"distributor_meta":false,"distributor_terms":false,"distributor_media":false,"distributor_original_site_name":"ÎÚÑ»´«Ã½ Colombia","distributor_original_site_url":"https:\/\/www.capgemini.com\/co-es","push-errors":false,"featured_image_url":"https:\/\/www.capgemini.com\/co-es\/wp-content\/uploads\/sites\/25\/2025\/07\/GettyImages-1090243542.jpg","author_title":"ÎÚÑ»´«Ã½","author_thumbnail_url":"https:\/\/www.capgemini.com\/co-es\/wp-content\/uploads\/sites\/25\/2021\/08\/cg-logo-3.png?w=330","author_thumbnail_alt":"","_links":{"self":[{"href":"https:\/\/www.capgemini.com\/co-es\/wp-json\/wp\/v2\/posts\/541436","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.capgemini.com\/co-es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.capgemini.com\/co-es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.capgemini.com\/co-es\/wp-json\/wp\/v2\/users\/699"}],"replies":[{"embeddable":true,"href":"https:\/\/www.capgemini.com\/co-es\/wp-json\/wp\/v2\/comments?post=541436"}],"version-history":[{"count":1,"href":"https:\/\/www.capgemini.com\/co-es\/wp-json\/wp\/v2\/posts\/541436\/revisions"}],"predecessor-version":[{"id":541445,"href":"https:\/\/www.capgemini.com\/co-es\/wp-json\/wp\/v2\/posts\/541436\/revisions\/541445"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.capgemini.com\/co-es\/wp-json\/wp\/v2\/media\/541437"}],"wp:attachment":[{"href":"https:\/\/www.capgemini.com\/co-es\/wp-json\/wp\/v2\/media?parent=541436"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.capgemini.com\/co-es\/wp-json\/wp\/v2\/categories?post=541436"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.capgemini.com\/co-es\/wp-json\/wp\/v2\/tags?post=541436"},{"taxonomy":"brand","embeddable":true,"href":"https:\/\/www.capgemini.com\/co-es\/wp-json\/wp\/v2\/brand?post=541436"},{"taxonomy":"service","embeddable":true,"href":"https:\/\/www.capgemini.com\/co-es\/wp-json\/wp\/v2\/service?post=541436"},{"taxonomy":"industry","embeddable":true,"href":"https:\/\/www.capgemini.com\/co-es\/wp-json\/wp\/v2\/industry?post=541436"},{"taxonomy":"partners","embeddable":true,"href":"https:\/\/www.capgemini.com\/co-es\/wp-json\/wp\/v2\/partners?post=541436"},{"taxonomy":"blog-topic","embeddable":true,"href":"https:\/\/www.capgemini.com\/co-es\/wp-json\/wp\/v2\/blog-topic?post=541436"},{"taxonomy":"content-group","embeddable":true,"href":"https:\/\/www.capgemini.com\/co-es\/wp-json\/wp\/v2\/content-group?post=541436"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}